All Policy articles
-
NewsTrump’s latest rule on research grants sidelines scientific merit and adds bureaucracy, academic groups warn
A new White House directive will see political appointees vet federal research funding decisions
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
News‘It’s carnage’: Former NIH director decries Trump administration efforts to slash research spending
Elias Zerhouni tells Chemistry World what’s changed from when he was appointed by a Republican president to the current Trump administration
-
NewsUS government cancels mRNA vaccine research
Experts fear industrial and academic research may move abroad after infectious disease projects cancelled
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
CareersThe additional costs of visas
On top of the financial expense, applications and renewals are slowing scientific progress and damaging researcher mental health
-
News‘An act of national self-harm’: UK visa system deters top chemistry talent
Immigration policies are making it much more difficult to get scientific talent to come to the UK at a time of global flux
-
NewsThe UN’s new scientific panel on chemical pollution faces an uncertain future
While the panel’s creation was welcomed, experts and researchers express doubts about its ambitions and structure
-
NewsEuropean Commission proposes partial suspension of Israel from Horizon Europe research programme
Move would affect start-ups and other innovative small businesses but not hit universities directly
-
NewsUK government roadmap will address presence of flea and tick treatment pesticides in rivers and lakes
Strategy aims to educate pet owners on responsible use of these products
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
-
BusinessTwo more European crackers to close
Sabic will not reopen UK plant and Dow will close another in Germany
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
NewsShake-up for unpopular procurement system that left Indian scientists with substandard supplies
Changes will see researchers, departments and universities able to buy equipment without going through government’s online portal
-
BusinessUK industrial strategy prioritises advanced manufacturing and life sciences
Government will subsidise electricity-intensive industries as part of support for eight key sectors
-
OpinionCritical metals supply strained
Conflict - both military and political - is having profound effects on supplies of a wide range of materials
-
OpinionThe future of oil refining in the UK
Can plants adapt to be compatible with a lower-carbon environment?
-
BusinessMilitary demand strains metal supply chains
Conflict and trade disputes have disrupted global supplies of specialist metals like hafnium, antimony and rare earths
-
OpinionIf the UK wants growth fuelled by R&D, universities need relief now
The spending review has left universities struggling with deficits with few options but to hope for good news